Federal contract award

68HE0221F0062

ESAT CONTRACT - TASK ORDER 001R02 SUPERFUND LABORATORY AND ANALYTICAL SUPPORT.

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyEnvironmental Protection Agency
OfficeREGION 2 CONTRACTING OFFICE
NAICS541380 — Testing Laboratories and Services
PSCB504 — Chemical/Biological Studies and Analysis
Parent award / vehicle68HE0121D0001
Set-asideNot reported
Pricing typeTIME AND MATERIALS
Obligations$3.3M
Current contract value$7.2M
Potential contract value / ceiling$7.2M
Start dateJul 22, 2021
Current end dateJan 18, 2027
Potential end dateJan 18, 2027
Latest award activitySep 3, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 29 of 29 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Sep 3, 2026P00028$20.8KESAT CONTRACT TASK ORDER 001R02-SUPERFUND DATA VALIDATION/REVIEW. THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING. P00028.
Jul 7, 2026P00027$64.0KESAT CONTRACT TASK ORDER 001R02-SUPERFUND DATA VALIDATION/REVIEW. THE PURPOSE OF THIS MODIFICATION IS TO PROVIDE INCREMENTAL FUNDING, EXTEND THE PERFORMANCE PERIOD 52.217-8 OPTION TO EXTEND SERVICES, AND UPDATE THE SCA WAGE SCHEDULE. P00027.
Apr 27, 2026P00026$-93.6KESAT CONTRACT TASK ORDER 001R02-SUPERFUND DATA VALIDATION/REVIEW. CLIN 3001, DE OBLIGATE UNUSED FUNDS. P00026.
Mar 18, 2026P00025$220.0KESAT CONTRACT TASK ORDER 001R02-SUPERFUND DATA VALIDATION/REVIEW. INCREMENTAL FUNDING, CLIN 4001. PERIOD OF PERFORMANCE 07/23/2025 TO 07/22/2026. P00025.
Dec 5, 2025P00024$220.0KESAT CONTRACT TASK ORDER 001R02-SUPERFUND DATA VALIDATION/REVIEW. INCREMENTAL FUNDING, CLIN 4001. PERIOD OF PERFORMANCE 07/23/2025 TO 07/22/2026. P00024.
Jul 3, 2025P00023$268.2KESAT CONTRACT TASK ORDER 001R02-SUPERFUND DATA VALIDATION/REVIEW. THE PURPOSE OF THIS MODIFICATION SHALL EXERCISE OPTION PERIOD 04, CLIN 4001. PERIOD OF PERFORMANCE 07/23/2025 TO 07/22/2026. P00023.
Feb 25, 2025P00022$255.0KESAT CONTRACT TASK ORDER 001R02-SUPERFUND DATA VALIDATION/REVIEW. THE PURPOSE OF MODIFICATION SHALL ADD INCREMENTAL FUNDING TO CLIN 3001. P00022.
Oct 31, 2024P00021$0ESAT CONTRACT TASK ORDER 001R02-SUPERFUND DATA VALIDATION/REVIEW. THE PURPOSE OF MODIFICATION P00021 IS TO SHIFT FUNDS IN THE AMOUNT OF $67,902.60. SHIFT FROM CLIN 2001. SHIFT TO CLIN 3001. P00021.
Oct 8, 2024P00020$195.0KESAT CONTRACT TASK ORDER 001R02-SUPERFUND DATA VALIDATION/REVIEW. INCREMENTAL FUNDING FOR TASK ORDER ON CLIN 3001, 07/23/2024 TO 07/22/2025. P00020.
Aug 8, 2024P00019$85.3KESAT CONTRACT TASK ORDER 001R02-SUPERFUND DATA VALIDATION/REVIEW. INCREMENTAL FUNDING FOR TASK ORDER ON CLIN 3001. P00019.
Jul 6, 2024P00018$90.0KESAT CONTRACT TASK ORDER 001R02-SUPERFUND DATA VALIDATION/REVIEW. EXERCISE OPTION PERIOD 3 (YEAR 4) POP: 7/23/24 - 7/22/25. P00018.
Jun 13, 2024P00017$110.0KESAT CONTRACT TASK ORDER 001R02-SUPERFUND DATA VALIDATION/REVIEW. INCREMENTAL FUNDING MODIFICATION; OPTION PERIOD 2 (YEAR 3), POP: 7/23/23 - 7/22/24. P00017.
Apr 26, 2024P00016$100.0KESAT CONTRACT TASK ORDER 001R02-SUPERFUND DATA VALIDATION/REVIEW. MODIFICATION FOR INCREMENTAL FUNDING MODIFICATION; P00016.
Mar 15, 2024P00015$50.0KESAT CONTRACT TASK ORDER 001R02-SUPERFUND DATA VALIDATION/REVIEW. MODIFICATION P00015 FOR INCREMENTAL FUNDING MODIFICATION.
Jan 10, 2024P00014$80.4KESAT CONTRACT TASK ORDER 001R02-SUPERFUND DATA VALIDATION/REVIEW. MODIFICATION P00013 FOR INCREMENTAL FUNDING MODIFICATION.
Nov 13, 2023P00013$0ESAT CONTRACT TASK ORDER 001R02-SUPERFUND DATA VALIDATION/REVIEW. SHIFT FUNDS FROM OPTION 1 TO OPTION 2.
Oct 25, 2023P00012$45.0KESAT CONTRACT TASK ORDER 001R02-SUPERFUND DATA VALIDATION/REVIEW. ADD INCREMENTAL FUNDING.
Sep 15, 2023P00011$100.0KESAT CONTRACT TASK ORDER 001R02-SUPERFUND DATA VALIDATION/REVIEW. MOD TO ADD INCREMENTAL FUNDING.
Apr 27, 2023P00010$0ESAT CONTRACT TASK ORDER 001R02-SUPERFUND DATA VALIDATION/REVIEW. MOD TO CORRECT DATE.
Apr 26, 2023P00009$130.6KESAT CONTRACT TASK ORDER 001R02-SUPERFUND DATA VALIDATION/REVIEW. EXERCISE OPTION PERIOD 2, 07/23/2023 TO 07/22/2024 (YR3), CLIN 2001.
Apr 20, 2023P00008$200.0KESAT CONTRACT - TASK ORDER 001R02-SUPERFUND DATA VALIDATION/REVIEW. MOD TO ADD FUNDING TO CLIN 1001 / OY01.
Feb 13, 2023P00007$130.0KESAT CONTRACT - TASK ORDER 001R02-SUPERFUND DATA VALIDATION/REVIEW. MOD TO ADD FUNDING TO CLIN 1001 / OY01.
Nov 23, 2022P00006$51.0KESAT CONTRACT - TASK ORDER 001R02-SUPERFUND DATA VALIDATION/REVIEW. MOD TO ADD FUNDING TO CLIN 1001 / OY01.
Sep 27, 2022P00005$0ESAT CONTRACT - TASK ORDER 001R02-SUPERFUND DATA VALIDATION/REVIEW. SHIFT FUNDS FROM BASE YEAR TO OY01.
Jun 29, 2022P00004$240.0KESAT CONTRACT - TASK ORDER 001R02 SUPERFUND LABORATORY AND ANALYTICAL SUPPORT. OPTION YEAR 01.
May 16, 2022P00003$130.0KESAT CONTRACT - TASK ORDER 001R02 SUPERFUND LABORATORY AND ANALYTICAL SUPPORT. ADD INCREMENTAL FUNDING.
Feb 14, 2022P00002$100.0KESAT CONTRACT - TASK ORDER 001R02 SUPERFUND LABORATORY AND ANALYTICAL SUPPORT. ADD INCREMENTAL FUNDING.
Dec 22, 2021P00001$78.6KESAT CONTRACT - TASK ORDER 001R02 SUPERFUND LABORATORY AND ANALYTICAL SUPPORT.
Jul 22, 20210$465.0KESAT CONTRACT - TASK ORDER 001R02 SUPERFUND LABORATORY AND ANALYTICAL SUPPORT.

Estimated positioning window

Oct 18, 2026 – Jan 16, 2027

Modeled likelihood: 85%. These are AcornBids estimates, not confirmed solicitation dates.

{
  "psc": "B504",
  "naics": "541380",
  "agency": "Environmental Protection Agency",
  "office": "REGION 2 CONTRACTING OFFICE",
  "vehicle": "68HE0121D0001",
  "incumbent": "TECHLAW CONSULTANTS INC",
  "known_forecast": false,
  "option_end_date": "2027-01-18",
  "contract_end_date": "2027-01-18",
  "latest_action_date": "2026-09-03",
  "modification_count": 29,
  "previous_solicitation": "68HE0221R0022",
  "historical_award_count": 5,
  "historical_cadence_days": 0
}

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.